Comera life sciences announces publication of study reinforcing caffeine's viscosity reducing capabilities

Data published in the journal of pharmaceutical sciences support further development of caffeine as a viscosity reducing agent for subcutaneous formulations of monoclonal antibodies

CMRA Ratings Summary

CMRA Quant Ranking